NTLA Stock News Today | Earnings, Events & Price Alerts
This article provides recent news and events related to Intellia Therapeutics (NTLA), including stock movements, analyst opinions, and reports on its gene editing treatment, Lonvo-z. Key highlights include positive Phase 3 results for Lonvo-z, the stock's performance after these announcements, and market reactions to broader economic news like the U.S.-Iran peace agreement.
https://intellectia.ai/en/stock/NTLA/news